Marc Schlaeppi
University of St.Gallen(CH)Kantonsspital St. Gallen(CH)
Publications by Year
Research Areas
Complementary and Alternative Medicine Studies, Melanoma and MAPK Pathways, Brain Metastases and Treatment, Diverse Scientific and Economic Studies, Human auditory perception and evaluation
Most-Cited Works
- → The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network(2013)466 cited
- → Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)(2011)80 cited
- → Sarcoidosis Induced by Interferon-α in Melanoma Patients(2010)35 cited
- → Successful Treatment of Acute Disseminated Intravascular Coagulation in a Patient with Metastatic Melanoma(2006)8 cited
- → First-line temozolomide (TEM) combined with bevacizumab (BEV) in metastatic melanoma (MM): A multicenter phase II trial (SAKK 50/07).(2010)6 cited
- → Anthroposophische Medizin in der Onkologie(2010)3 cited
- → Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial(2023)2 cited
- → Predictive and prognostic potential of angiogenic serum factors and circulating endothelial cells in metastatic melanoma patients receiving temozolamide plus bevacizumab (SAKK 50/07).(2010)1 cited
- → The price of tumor control(2013)1 cited
- → Grenzen und Nutzen nichtkontrollierter therapiebezogener Fallbeobachtungen(2010)1 cited